The whistleblowing drama behind Astellas's suspension from the ABPI

Deborah Cohen; Shai Mulinari; Piotr Ozieranski

doi:10.1136/bmj.l4353

The whistleblowing drama behind Astellas's suspension from the ABPI

Deborah Cohen, Shai Mulinari, Piotr Ozieranski

Research output: Contribution to journal › Article

3 Citations (SciVal)

336 Downloads (Pure)

Original language	English
Article number	l4353
Journal	British Medical Journal
Volume	366
DOIs	https://doi.org/10.1136/bmj.l4353
Publication status	Published - 2 Jul 2019

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1136/bmj.l4353

AstellasWord.pdf
This is the author accepted manuscript of an article published in final form in Cohen, D, Mulinari, S & Ozieranski, P 2019, 'The whistleblowing drama behind Astellas's suspension from the ABPI', British Medical Journal, vol. 366, l4353 and available online via: https://doi.org/10.1136/bmj.l4353
Accepted author manuscript, 590 KB

Cite this

@article{9f72395ba3cc4d0983a51b997b6153b4,

title = "The whistleblowing drama behind Astellas's suspension from the ABPI",

author = "Deborah Cohen and Shai Mulinari and Piotr Ozieranski",

year = "2019",

month = jul,

day = "2",

doi = "10.1136/bmj.l4353",

language = "English",

volume = "366",

journal = "British Medical Journal",

issn = "0959-8146",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - The whistleblowing drama behind Astellas's suspension from the ABPI

AU - Cohen, Deborah

AU - Mulinari, Shai

AU - Ozieranski, Piotr

PY - 2019/7/2

Y1 - 2019/7/2

UR - http://www.scopus.com/inward/record.url?scp=85068472995&partnerID=8YFLogxK

U2 - 10.1136/bmj.l4353

DO - 10.1136/bmj.l4353

M3 - Article

C2 - 31266743

SN - 0959-8146

VL - 366

JO - British Medical Journal

JF - British Medical Journal

M1 - l4353

ER -

The whistleblowing drama behind Astellas's suspension from the ABPI

ASJC Scopus subject areas

Access to Document

Other files and links

What can be learnt from the new pharmaceutical industry payment disclosures?

Cite this

The whistleblowing drama behind Astellas's suspension from the ABPI

ASJC Scopus subject areas

Access to Document

Other files and links

Projects

What can be learnt from the new pharmaceutical industry payment disclosures?

Cite this